HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 335 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $888,000 | -62.1% | 20,785 | -76.7% | 0.02% | -75.5% |
| Q3 2020 | $2,344,000 | +589.4% | 89,200 | +413.4% | 0.10% | +827.3% |
| Q1 2018 | $340,000 | -45.2% | 17,373 | -43.3% | 0.01% | -31.2% |
| Q4 2017 | $621,000 | +90.5% | 30,637 | +63.3% | 0.02% | +100.0% |
| Q3 2017 | $326,000 | -44.8% | 18,765 | -59.3% | 0.01% | -55.6% |
| Q2 2017 | $591,000 | +65.1% | 46,103 | +73.0% | 0.02% | +50.0% |
| Q3 2015 | $358,000 | – | 26,655 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |